Patient sleeps with the patient-applied Onera home Polysomnography (Onera hPSG) solution. The international multicenter study ...
Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical ...
Stocktwits on MSN
ASBP stock soars 32% after favorable feedback from FDA for its aspirin – retail expects licensing negotiations soon
Aspire does not expect to conduct additional studies beyond its currently planned multicenter crossover clinical trial. ・The ...
Insilico Medicine("Insilico"), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the first patient has been dosed in a global multicenter ...
A multicenter, phase 2 study of atezolizumab plus bevacizumab (atezo+bev) combination therapy in patients with unresectable hepatocellular carcinoma (HCC) and Child–Pugh class B cirrhosis: CHALLENGE ...
Moncton, New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - June 17, 2025) - Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today ...
New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback